Baird Medical Sponsored and Showcased Advanced Microwave Ablation (MWA) Technology at the Sichuan Medical Association Thyroid Disease Conference
Rhea-AI Summary
Baird Medical (NASDAQ: BDMD), a leader in minimally invasive microwave ablation (MWA) technology, sponsored and participated in the 4th Sichuan Medical Association Thyroid Disease Academic Conference in China. The company showcased its advanced MWA technology for thyroid nodules, featuring larger ablation zones and shorter treatment times.
During the conference, which brought together prominent thyroid specialists and healthcare professionals, Baird Medical engaged in discussions with medical leaders and presented its innovative solutions. Chairwoman Haimei Wu emphasized the company's commitment to advancing thyroid disease treatment and improving patient outcomes through technological innovation and professional collaboration.
Positive
- Successfully showcased advanced MWA technology with improved features (larger ablation zones, shorter treatment times)
- Strengthened market presence in China's healthcare sector through conference sponsorship
Negative
- None.
News Market Reaction
On the day this news was published, BDMD gained 10.93%, reflecting a significant positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
The highly regarded conference gathered top thyroid specialists and healthcare professionals to promote best practices in thyroid disease diagnosis and treatment. Baird Medical's sponsorship underscored its commitment to advancing medical innovation and fostering academic collaboration in
During the event, Baird Medical presented its state-of-the-art MWA technology for thyroid nodules. The innovative solution, designed to deliver larger ablation zones and shorter treatment times, attracted significant attention for its potential to improve patient outcomes and set new standards for minimally invasive care. The company also engaged in high-level discussions with medical leaders, further solidifying its position as a key player in the global healthcare market.
"Our participation in this prominent conference reflected Baird Medical's commitment to supporting advancements in thyroid disease treatment," said Haimei Wu, Chairwoman of Baird Medical. "By presenting our latest MWA technology, we contributed to the ongoing dialogue on improving treatment options and patient outcomes. We remain dedicated to collaborating with medical professionals to promote innovation and enhance care standards globally."
About Baird Medical
Baird Medical is a leading provider of minimally invasive microwave ablation (MWA) technology, offering advanced treatment solutions for conditions such as thyroid nodules, breast disease, uterine fibroids, and liver cancer. A publicly traded company on NASDAQ, Baird Medical is dedicated to enhancing patient care through precision, efficiency, and safety in its innovative medical devices. For more information, please visit https://bairdmed.com/
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts and generally relate to future events or Baird Medical's future financial or operational performance. In some cases, you can identify forward-looking statements by terminology such as "may," "might," "will," "should," "expect," "intend," "plan," "anticipate," "believe," "estimate," "predict," "potential," "continue," or the negative of these terms or other similar expressions.
These forward-looking statements are subject to risks, uncertainties, and assumptions that could cause actual results or outcomes to differ materially from those expressed or implied. These statements are based on estimates and assumptions that, while considered reasonable by Baird Medical and its management, are inherently uncertain. Risks and uncertainties may emerge over time, and it is not possible to anticipate all potential factors that could affect Baird Medical's business and financial performance.
Factors that could cause actual results to differ materially include, but are not limited to: (1) the risk that Baird Medical may not achieve its expansion goals in
Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. Baird Medical undertakes no obligation to update or revise forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. All forward-looking statements in this press release are qualified in their entirety by this cautionary statement.
View original content to download multimedia:https://www.prnewswire.com/news-releases/baird-medical-sponsored-and-showcased-advanced-microwave-ablation-mwa-technology-at-the-sichuan-medical-association-thyroid-disease-conference-302342737.html
SOURCE BDMD
FAQ
What new MWA technology features did Baird Medical (BDMD) present at the Sichuan conference?
How is Baird Medical (BDMD) expanding its presence in the Chinese healthcare market?
What are the key benefits of Baird Medical's (BDMD) new MWA technology for patients?
What was the significance of BDMD's participation in the Sichuan Medical Association conference?
